BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

August 2006

SOLVO Biotechnology is launching the revolutionary PREDEASYTM ATPase Assay Kit.

SOLVO Biotechnology is now introducing a new, intelligent, web-based Online Technical Support System to provide a secure interface for all clients and partners!

CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES SENIOR MANAGEMENT APPOINTMENT

Auto-Montage Pro Helps Speed up California’s Agricultural Import Process

GENTRONIX INTRODUCES NEXT GENERATION GENOTOXICITY SCREENING ASSAY AT DDT

mtm laboratories extends marketing & sales team

Phosphagenics Sign Agreement with Major Cosmetic Company

Cellexus Biosystems announces the world-wide launch of the CellMaker Lite disposable bioreactor, with backing from the British Department of Trade and Industry.

Cellexus Biosystems appoints JM Finn as Company’s Corporate Advisor

Directed molecular evolution: lifecycle management for biologics

Phosphagenics successfully delivers insulin across the skin in humans

ABLYNX COMPLETES €40 MILLION (~US$50 MILLION) SERIES C FINANCING – ONE OF THE TWO LARGEST PRIVATE PLACEMENTS IN EUROPEAN BIOTECH THIS YEAR

Cobra Strengthens Management Team

Fresenius Kabi and Sandoz to cooperate in the development of an HESylated biopharmaceutical drug

Peakadilly closes series A financing at €14.5 million ($18.4 million)

Leading US clinician to present on Oxford Biomedica’s TROVAX® at cancer conference

Peakdale Introduces peakfinder™ Chemogenetic Kinase Arrays

Thermo Releases Enhanced Heraeus® Pico™ & Fresco™ Microcentrifuges

US healthcare payers turn to reimbursement to contain costs

How bugs avoid getting sick after sex

Thermo Releases Varioskan Flash Spectral Scanning Multimode Microplate Reader

LifeCycle Pharma appoints internationally experienced pharmaceutical executive as new President and Chief Executive Officer

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO JAPANESE LIFE SCIENCE COMPANIES

SOLEXA ANNOUNCES SECOND QUARTER 2006 FINANCIAL RESULTS

Dr John Brown joins SingVax Board as Chairman - Expanded Board positions SingVax for further growth

Viral Genetics’ AIDS Study Results at XVI International AIDS Conference

Company Behind Lifesaving Technology Secures Crucial Investment from South West Ventures Fund and GEIF Ventures

AstraZeneca's Symbicort the first of many new combination drugs to come

SIGMA-ALDRICH (NASDAQ: SIAL) DECLARES QUARTERLY DIVIDEND AND ADDS 5 MILLION SHARES TO REPURCHASE AUTHORIZATION

TTP LabTech’s comPOUND® Library Expansion Shows iNovacia’s Early Success

SYNTAXIN APPOINTS PATRICK J. DOYLE AS CHIEF EXECUTIVE OFFICER

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO YAMATAKE CORPORATION TO MANUFACTURE AND MARKET MICROARRAYS

Syrris launch new innovative tool for laboratory synthesis - atlas™: simple, flexible and cost effective

Diverse challenges await generics industry

Hybrigenics appoints Dr Ehmer to its Board of Directors

Immutep Announces That ImmuFact(R) IMP321 Has Entered a Phase I Chemoimmunotherapy Trial in Breast Cancer

DOE to Invest $250 Million in New Bioenergy Centers--Basic Genomics Research on the Development of Biofuels to be Accelerated

SOLEXA TO HOLD SECOND QUARTER 2006 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 14

Drug Patent Expirations in August 2006

Study results confirm superior performance of Oxford Immunotec Ltd’s T-SPOT®.TB over other diagnostic tests for tuberculosis

ESBATech Closes CHF 50M ($41M) Series B Venture Financing

deltaDOT strengthens senior team with appointment of new Chairman

A Full Pipeline of Follow-on TNF-Antagonists

OXFORD GENE TECHNOLOGY GRANTS MICROARRAY LICENSE TO NGK INSULATORS LTD. TO MANUFACTURE, SELL AND OEM MICROARRAYS

SOLEXA AND NEW ENGLAND BIOLABS ANNOUNCE ENZYME SUPPLY AGREEMENT

Genomic Vision names Dr Aaron Bensimon President and CEO

Antiarrhythmics: RSD1235 woes reduce market potential but not clinical impact

Research update on York Pharma's Sabarep - YP001

Catachem - URINE CSF PROTEIN (MICROPROTEIN)

Catachem - SORBITOL DEHYDROGENASE (SDH)

Catachem - NONESTERIFIED FATTY ACIDS (NEFA)

Catachem - BILE ACIDS (LIQUID)

Catachem - ETHYLENE GLYCOL POISONING

Syngene - New Application of Dyversity - Imaging Deep Purple Stained Protein Gels

Exiqon Licenses micro-rnas FOR DIAGNOSTIC USE from Max Planck SOCIETY and the Rockefeller universitY

SIGMA-ALDRICH (NASDAQ: SIAL) REPORTS 14.3% GAIN IN Q2 2006

Oxford Immunotec Strengthens Team with Two Strategic Board Appointments

Member States reach agreement on Framework Programme for Research and Innovation in Europe

All-in-one systems for live cell imaging - Olympus cell^M and cell^R for multicolour fluorescence 3D imaging

Phosphagenics commences Phase l clinical trial for transdermal insulin gel

DYNAL Bead Based Separations Powerful new tool to revolutionise immunotherapy

SOLEXA NAMES BROCK SIEGEL CHIEF OPERATING OFFICER

BIACORE HALF-YEAR REPORT JANUARY - JUNE 2006

Hype surrounding new genome-based medical technologies is unrealistic

West Pharmaceuticals Wins Top Safety Award

Cobra Extends Agreement to Manufacture AA4500 for Auxilium Pharmaceuticals, Inc.

CeNeS and ERGOMED announce Revenue Sharing and Co-Development Agreement

CeNeS acquires transdermal patch formulation IP relating to its neuropathic pain compound CNS 5161 from ALZA Corporation

CeNeS: Extract from AGM Statement

BioInvent Interim Report: 1 January - 30 June 2006

Isogenica Renews Research Collaboration With AstraZenec

SOLEXA ANNOUNCES INITIAL SYSTEM SHIPMENTS

SINGLE BATCH PRODUCT SUPPLY PACKAGES FROM SOLVO

Thermo’s New HCS WorkCell Selected by Emory University 

Eden Biodesign and Liverpool University develop new therapeutics for cancer

mtm laboratories makes two senior clinical research appointments

Powdermed to conduct clinical trial of its novel DNA-based H5N1 (avian) influenza vaccine in London

Directed Molecular Evolution: Product lifecycle management for biologics

Tibotec and J&J cleared to launch Aptivus rival

LTKfarma announces its creation and names advisory board

Syntaxin Wins Collaborative Dti Grant To Investigate Biopharmaceutical Processing

ibidi publishes new data on homogeneous cell growth inside µ-channels

SYNTAXIN WINS COLLABORATIVE DTI GRANT TO INVESTIGATE BIOPHARMACEUTICAL PROCESSING

Surepath Solutions Ltd are pleased to announce the launch of a new range of P650 compliant packaging systems for the transporation of Diagnostic Specimens

Blockbusters drugs account for a third of global pharmaceutical sales

URCH Publishing launches comprehensive guide to pharmaceutical pricing systems in Western Europe

URCH Publishing launches comprehensive overview of pharmaceutical pricing systems in MENA region

Economic liberalisation will drive Middle East pharma market size to more than $12bn by 2010

Living Cell Technologies granted diabetes patent in the US

SOLEXA NAMES RICHARD H. LUSSIER VICE PRESIDENT, SALES AND FIELD OPERATIONS

New Software for Automated Zone Analysis System Improves Speed and Accuracy of Antibiotic Sensitivity Testing

Drug Patent Expirations in July 2006

Building Biotechnology available for pre-order - Ships August 1st

DanioLabs starts clinical trial with new treatments for Parkinson's disease symptoms

Phosphagenics receives ethics approval for Phase I clinical trials of its transdermal insulin delivery product

SOLEXA JOINS RUSSELL 3000 INDEX

Inpharmatica's Admensa Interactive(TM) Licensed by Lilly

Cellectis and Bayer CropScience enter into a collaboration to use Meganuclease technology in plants

Cellexus Biosystems exhibiting at UK’s Top Investor Show

Cellexus Biosystems moves to a new 25,000 sq.ft (2,322 m2) headquarters in Cambridgeshire

Cellexus Biosystems achieves significant milestone

Cellexus Biosystems appoints Rob Molloy and Bob Cumming as non-executive Directors

Cellexus Biosystems Admission to Ofex

Cellexus Biosystems to supply patent-protected oxygen and pH detectors from Polestar Technologies as part of its CellMaker LiteTM disposable bioreactor suite

SIGMA-ALDRICH LAUNCHES NEW AND EXPANDED 5th EDITION OF THE SIGMA-RBI HANDBOOK OF RECEPTOR CLASSIFICATION AND SIGNAL TRANSDUCTION

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006  ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.